Yatharth Hospital & Trauma Care Services Limited — Investor Meet, 04-06-2025: Analysts/Institutional Investor Meet/Con. Call Updates

Yatharth Hospitals has announced a board meeting to consider the financial results for the quarter and half-year.

FY25 revenue rose 31% to INR880.5 Cr, EBITDA grew 22% to INR220.2 Cr (25% margin), and PAT increased 14% to INR130.6 Cr. Q4 revenue was up 30% YoY to INR231.8 Cr; EBITDA rose 23% to INR57 Cr, with a slight margin dip from start-up costs. Inpatient volumes jumped 34%, outpatient by 16%. EBITDA breakeven expected within 12–15 months for new hospitals in Delhi and Faridabad. Capex guidance stands at ~INR300 Cr annually. ARPOB rose 7% to INR31,441, led by strong specialty cases and improving revenue mix. Receivables remain high but cash conversion is solid. Focus remains on clinical excellence, super-specialty growth, and medical value travel. Balance sheet remains strong with net cash of INR503 Cr.